
Iris Formulation Private Limited
About Iris Formulation Private Limited
Data last updated:
Iris Formulation Private Limited is a private limited company based in Elegance Productivity, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2006PTC047660.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Praveen Mittal and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at 205 Elegance Productivityroad Vadodara 390020, Gujarat, India.
Company details
Contact details
Iris Formulation Private Limited's registered office is in Elegance Productivity, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address205 Elegance Productivityroad Vadodara 390020, Gujarat, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Iris Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iris Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Iris Formulation Private Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Iris Formulation Private Limited, buy the company report.
Board of directors of Iris Formulation Private Limited
Iris Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Mittal Also directs: Shree Navrang Suppliers Private Limited | Director | 03 Feb 2006 | 20 Years 9 Months | Current |
| Rakesh Kumar | Director | 03 Feb 2006 | 20 Years 9 Months | Current |
Auditor
Iris Formulation Private Limited is audited by M. NUWAL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. NUWAL & CO. | FY 2017 | 048164 |
Shareholding
The shareholding of Iris Formulation Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Iris Formulation Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Iris Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iris Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Iris Formulation Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Iris Formulation Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Manju Chaudhary ceased to be Director on 29 Dec 2017.
Frequently asked questions
Iris Formulation is an active private limited company based in Elegance Productivity, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2006 (20+ years old) and is registered under CIN U24230GJ2006PTC047660.
Iris Formulation has 2 current directors:
- Praveen Mittal - Director
- Rakesh Kumar - Director
The latest financial statements of Iris Formulation on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Iris Formulation is U24230GJ2006PTC047660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iris Formulation was incorporated on 03 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Manju Chaudhary ceased to be Director on 29 Dec 2017. Rajeev Kumar ceased to be Director on 25 Mar 2015. Praveen Mittal was appointed as Director on 03 Feb 2006. Iris Formulation has 4 board changes on record in total.
The registered office of Iris Formulation is at 205 Elegance Productivityroad Vadodara 390020, Gujarat, India.
Iris Formulation operates in the pharma industry, in the drug formulation and development segment.
Iris Formulation can be reached at its registered office: 205 Elegance Productivityroad Vadodara 390020, Gujarat, India.
Iris Formulation is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.

